Cenobamate’s effect on mood and seizure frequency

Key Points

• Mood improvement was observed alongside a decrease in seizure frequency with cenobamate treatment.
• The study reported an average seizure frequency reduction of 40% over three months in participants treated with cenobamate.
• Analysis involved assessing both mood and seizure data from clinical evaluations, highlighting the dual benefit of the intervention.
• Further validation of cenobamate's effects is needed across diverse patient populations to confirm findings.